

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nucleotide transmembrane transport (GO:1901679) | 8.87930702 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 8.60138133 |
| 3 | opsonization (GO:0008228) | 8.33836227 |
| 4 | protein import into peroxisome matrix (GO:0016558) | 8.32524441 |
| 5 | negative regulation of complement activation (GO:0045916) | 8.24223353 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.98500679 |
| 7 | negative regulation of cell killing (GO:0031342) | 7.98500679 |
| 8 | T-helper 1 type immune response (GO:0042088) | 7.74905478 |
| 9 | detection of molecule of bacterial origin (GO:0032490) | 7.29808440 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.09660161 |
| 11 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 6.81188041 |
| 12 | regulation of protein homooligomerization (GO:0032462) | 6.79548617 |
| 13 | negative regulation of protein activation cascade (GO:2000258) | 6.66786164 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.38054111 |
| 15 | leukocyte migration involved in inflammatory response (GO:0002523) | 6.37706397 |
| 16 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.34032382 |
| 17 | antigen processing and presentation via MHC class Ib (GO:0002475) | 6.14775384 |
| 18 | microglial cell activation (GO:0001774) | 5.85299867 |
| 19 | establishment of protein localization to peroxisome (GO:0072663) | 5.68848309 |
| 20 | protein localization to peroxisome (GO:0072662) | 5.68848309 |
| 21 | protein targeting to peroxisome (GO:0006625) | 5.68848309 |
| 22 | histone H4-K12 acetylation (GO:0043983) | 5.65203851 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 5.38428128 |
| 24 | negative regulation of humoral immune response (GO:0002921) | 5.37497090 |
| 25 | positive regulation of isotype switching (GO:0045830) | 5.37257286 |
| 26 | peroxisomal transport (GO:0043574) | 5.36683901 |
| 27 | lipopolysaccharide metabolic process (GO:0008653) | 5.21946418 |
| 28 | lipopolysaccharide biosynthetic process (GO:0009103) | 5.10596211 |
| 29 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 5.04573250 |
| 30 | positive regulation of macrophage activation (GO:0043032) | 5.00888211 |
| 31 | presynaptic membrane assembly (GO:0097105) | 4.88449169 |
| 32 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.84552367 |
| 33 | regulation of respiratory burst (GO:0060263) | 4.83798898 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 4.77715176 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.69522741 |
| 36 | positive regulation of DNA recombination (GO:0045911) | 4.65031901 |
| 37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.61121104 |
| 38 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.57193507 |
| 39 | negative regulation of glycogen biosynthetic process (GO:0045719) | 4.47124821 |
| 40 | positive regulation of mast cell degranulation (GO:0043306) | 4.41453081 |
| 41 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.41453081 |
| 42 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.41252421 |
| 43 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.41252421 |
| 44 | nucleotide transport (GO:0006862) | 4.38461728 |
| 45 | rRNA catabolic process (GO:0016075) | 4.29883657 |
| 46 | detection of external biotic stimulus (GO:0098581) | 4.26729200 |
| 47 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 4.16976847 |
| 48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.16241068 |
| 49 | presynaptic membrane organization (GO:0097090) | 4.12673155 |
| 50 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.11834150 |
| 51 | DNA deamination (GO:0045006) | 4.10823094 |
| 52 | positive regulation of interleukin-17 production (GO:0032740) | 4.06660609 |
| 53 | adaptation of signaling pathway (GO:0023058) | 4.06338577 |
| 54 | macrophage chemotaxis (GO:0048246) | 3.97760712 |
| 55 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.91680386 |
| 56 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.89452892 |
| 57 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.84564860 |
| 58 | inner ear receptor cell development (GO:0060119) | 3.83566376 |
| 59 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.82557895 |
| 60 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81691957 |
| 61 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.77715125 |
| 62 | positive regulation of B cell mediated immunity (GO:0002714) | 3.77391212 |
| 63 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.77391212 |
| 64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.76968120 |
| 65 | peroxisome organization (GO:0007031) | 3.72380746 |
| 66 | negative regulation of phagocytosis (GO:0050765) | 3.66614262 |
| 67 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.65329794 |
| 68 | response to hydroperoxide (GO:0033194) | 3.62323694 |
| 69 | regulation of isotype switching (GO:0045191) | 3.60670090 |
| 70 | regulation of apoptotic cell clearance (GO:2000425) | 3.55924109 |
| 71 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.55406125 |
| 72 | postsynaptic membrane organization (GO:0001941) | 3.53619273 |
| 73 | ovulation from ovarian follicle (GO:0001542) | 3.53574648 |
| 74 | basement membrane organization (GO:0071711) | 3.53033440 |
| 75 | negative regulation of glycogen metabolic process (GO:0070874) | 3.50316995 |
| 76 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.49913126 |
| 77 | positive regulation of vascular permeability (GO:0043117) | 3.46415416 |
| 78 | detection of biotic stimulus (GO:0009595) | 3.45674150 |
| 79 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.45160976 |
| 80 | regulation of mast cell activation (GO:0033003) | 3.43332855 |
| 81 | regulation of protein oligomerization (GO:0032459) | 3.42943843 |
| 82 | positive regulation of cell killing (GO:0031343) | 3.40528588 |
| 83 | protein-cofactor linkage (GO:0018065) | 3.37150189 |
| 84 | regulation of energy homeostasis (GO:2000505) | 3.32819503 |
| 85 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.30536531 |
| 86 | cellular response to interleukin-15 (GO:0071350) | 3.30202277 |
| 87 | vocalization behavior (GO:0071625) | 3.28616052 |
| 88 | positive regulation of neutrophil migration (GO:1902624) | 3.28159720 |
| 89 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.28159720 |
| 90 | leukocyte aggregation (GO:0070486) | 3.27334419 |
| 91 | lymphocyte migration (GO:0072676) | 3.26640560 |
| 92 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.25955319 |
| 93 | regulation of growth of symbiont in host (GO:0044126) | 3.25955319 |
| 94 | negative regulation of growth of symbiont in host (GO:0044130) | 3.25955319 |
| 95 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.25955319 |
| 96 | extracellular negative regulation of signal transduction (GO:1900116) | 3.25537726 |
| 97 | extracellular regulation of signal transduction (GO:1900115) | 3.25537726 |
| 98 | cGMP metabolic process (GO:0046068) | 3.25287265 |
| 99 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.22600210 |
| 100 | negative regulation of innate immune response (GO:0045824) | 3.22431776 |
| 101 | neuron cell-cell adhesion (GO:0007158) | 3.22274117 |
| 102 | positive regulation of immunoglobulin production (GO:0002639) | 3.22103575 |
| 103 | cellular defense response (GO:0006968) | 3.21339755 |
| 104 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.21270020 |
| 105 | regulation of cell killing (GO:0031341) | 3.21140549 |
| 106 | cerebellar granule cell differentiation (GO:0021707) | 3.20758555 |
| 107 | regulation of extracellular matrix disassembly (GO:0010715) | 3.18510982 |
| 108 | regulation of mast cell degranulation (GO:0043304) | 3.17628425 |
| 109 | macrophage activation (GO:0042116) | 3.16096484 |
| 110 | startle response (GO:0001964) | 3.15669519 |
| 111 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.12300330 |
| 112 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.09526686 |
| 113 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.08465856 |
| 114 | phagosome maturation (GO:0090382) | 3.07526767 |
| 115 | positive regulation of T cell mediated immunity (GO:0002711) | 3.07219530 |
| 116 | cGMP biosynthetic process (GO:0006182) | 3.04593965 |
| 117 | thrombin receptor signaling pathway (GO:0070493) | 3.03619682 |
| 118 | response to interleukin-15 (GO:0070672) | 3.03433459 |
| 119 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.03064306 |
| 120 | positive regulation of leukocyte degranulation (GO:0043302) | 3.02656056 |
| 121 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.02411123 |
| 122 | intracellular protein transmembrane import (GO:0044743) | 2.99391019 |
| 123 | L-serine transport (GO:0015825) | 2.99214884 |
| 124 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.97481640 |
| 125 | mast cell activation involved in immune response (GO:0002279) | 2.97421357 |
| 126 | mast cell degranulation (GO:0043303) | 2.97421357 |
| 127 | detection of bacterium (GO:0016045) | 2.96855662 |
| 128 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.95883009 |
| 129 | detection of other organism (GO:0098543) | 2.93997185 |
| 130 | cAMP catabolic process (GO:0006198) | 2.93380943 |
| 131 | regulation of monocyte differentiation (GO:0045655) | 2.93076896 |
| 132 | keratan sulfate biosynthetic process (GO:0018146) | 2.92349442 |
| 133 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92315391 |
| 134 | regulation of neutrophil chemotaxis (GO:0090022) | 2.92167333 |
| 135 | regulation of neutrophil migration (GO:1902622) | 2.92167333 |
| 136 | positive regulation of adaptive immune response (GO:0002821) | 2.91494847 |
| 137 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.91439337 |
| 138 | type I interferon signaling pathway (GO:0060337) | 2.90714918 |
| 139 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.88332359 |
| 140 | regulation of T cell tolerance induction (GO:0002664) | 2.88074858 |
| 141 | regulation of complement activation (GO:0030449) | 2.83022587 |
| 142 | cyclic nucleotide catabolic process (GO:0009214) | 2.78535330 |
| 143 | serine transport (GO:0032329) | 2.78441143 |
| 144 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.76437431 |
| 145 | transferrin transport (GO:0033572) | 2.75787458 |
| 146 | cellular extravasation (GO:0045123) | 2.75709903 |
| 147 | defense response to Gram-negative bacterium (GO:0050829) | 2.75314100 |
| 148 | glucocorticoid biosynthetic process (GO:0006704) | 2.74336018 |
| 149 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.73230587 |
| 150 | angiogenesis involved in wound healing (GO:0060055) | 2.69655104 |
| 151 | cGMP-mediated signaling (GO:0019934) | 2.68619848 |
| 152 | vesicle targeting (GO:0006903) | 2.66108492 |
| 153 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.65915425 |
| 154 | chondrocyte proliferation (GO:0035988) | 2.62726756 |
| 155 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.62491343 |
| 156 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.61282536 |
| 157 | gland morphogenesis (GO:0022612) | 2.61251811 |
| 158 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.60186677 |
| 159 | lung lobe morphogenesis (GO:0060463) | 2.59696554 |
| 160 | ferric iron transport (GO:0015682) | 2.55831934 |
| 161 | trivalent inorganic cation transport (GO:0072512) | 2.55831934 |
| 162 | myeloid cell activation involved in immune response (GO:0002275) | 2.54881081 |
| 163 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.51986152 |
| 164 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.50771256 |
| 165 | positive regulation of hair cycle (GO:0042635) | 2.49029493 |
| 166 | positive regulation of hair follicle development (GO:0051798) | 2.49029493 |
| 167 | regulation of protein activation cascade (GO:2000257) | 2.48870523 |
| 168 | hydrogen peroxide catabolic process (GO:0042744) | 2.48082132 |
| 169 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.47461215 |
| 170 | regulation of alkaline phosphatase activity (GO:0010692) | 2.44809037 |
| 171 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.44780712 |
| 172 | tachykinin receptor signaling pathway (GO:0007217) | 2.43902571 |
| 173 | collagen fibril organization (GO:0030199) | 2.43848907 |
| 174 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.42633516 |
| 175 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.42633516 |
| 176 | modulation by symbiont of host immune response (GO:0052553) | 2.42633516 |
| 177 | positive regulation by symbiont of host defense response (GO:0052509) | 2.42633516 |
| 178 | modulation by symbiont of host defense response (GO:0052031) | 2.42633516 |
| 179 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.42633516 |
| 180 | cellular response to ammonium ion (GO:0071242) | 2.42510287 |
| 181 | superoxide anion generation (GO:0042554) | 2.40609512 |
| 182 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.38071059 |
| 183 | B cell receptor signaling pathway (GO:0050853) | 2.37874038 |
| 184 | prostate gland growth (GO:0060736) | 2.37425867 |
| 185 | gamma-aminobutyric acid transport (GO:0015812) | 2.36497997 |
| 186 | protein localization to synapse (GO:0035418) | 2.35845713 |
| 187 | synaptic vesicle exocytosis (GO:0016079) | 2.34858252 |
| 188 | positive regulation of respiratory burst (GO:0060267) | 12.2189792 |
| 189 | maturation of 5.8S rRNA (GO:0000460) | 10.5192182 |
| 190 | negative regulation of protein oligomerization (GO:0032460) | 10.1529365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 5.55586288 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.26031611 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.84699051 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.02254136 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.87667925 |
| 6 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 3.35891938 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.21409911 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.12037497 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.04618263 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.02862287 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.77203036 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.62020361 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61404076 |
| 14 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.53587528 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.52644385 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.52401051 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.52293968 |
| 18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.43277111 |
| 19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.35132316 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.32428695 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31611982 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26451993 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21515781 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.21222604 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.20603611 |
| 26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.18291602 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.18291602 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.16475235 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.15301153 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12892157 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09798994 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.08710611 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.08662424 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.08119993 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.06301717 |
| 36 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.02381039 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.02347044 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00564348 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.96268481 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.95270457 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95251856 |
| 42 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.94916131 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.93794806 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.93434363 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.92809861 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91341661 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89020302 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84990067 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82921381 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82834212 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.78807216 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.78310736 |
| 53 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.77588756 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.77456222 |
| 55 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.77170249 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.75447937 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73883297 |
| 58 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73397309 |
| 59 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.71706199 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.70501577 |
| 61 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.69353398 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64524815 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64443645 |
| 64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.62345037 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60481080 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59162134 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52627322 |
| 68 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51999758 |
| 69 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.51620365 |
| 70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48729077 |
| 71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48407096 |
| 72 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.47134364 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45095248 |
| 74 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44815110 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43714816 |
| 76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.42880342 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.41992257 |
| 78 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.41571406 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39046334 |
| 80 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38834983 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.37851347 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37625406 |
| 83 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36820596 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36442167 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35043409 |
| 86 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.33312674 |
| 87 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33185961 |
| 88 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31249069 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30318761 |
| 90 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29653975 |
| 91 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28191244 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28122740 |
| 93 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.27498633 |
| 94 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.27383586 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27282508 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26657120 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26644245 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 1.26362352 |
| 99 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26116114 |
| 100 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24943177 |
| 101 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24778173 |
| 102 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24615872 |
| 103 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24066007 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22621255 |
| 105 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21788339 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21151770 |
| 107 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20813580 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20246697 |
| 109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19782945 |
| 110 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.19648344 |
| 111 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19589677 |
| 112 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19219365 |
| 113 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.18925330 |
| 114 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18747909 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18412708 |
| 116 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.16313854 |
| 117 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15925158 |
| 118 | MAF_26560356_Chip-Seq_TH2_Human | 1.15488477 |
| 119 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15330618 |
| 120 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15089743 |
| 121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14816879 |
| 122 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13912762 |
| 123 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12703745 |
| 124 | MYC_22102868_ChIP-Seq_BL_Human | 1.12382779 |
| 125 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12359306 |
| 126 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11873328 |
| 127 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10758773 |
| 128 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.10332952 |
| 129 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09444510 |
| 130 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09143964 |
| 131 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09106749 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08773604 |
| 133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08295701 |
| 134 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.07704859 |
| 135 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07031828 |
| 136 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05814689 |
| 137 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.05637315 |
| 138 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05513579 |
| 139 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04064360 |
| 140 | AR_19668381_ChIP-Seq_PC3_Human | 1.03886741 |
| 141 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03162407 |
| 142 | JUN_21703547_ChIP-Seq_K562_Human | 1.03093133 |
| 143 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03075721 |
| 144 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02755543 |
| 145 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02511392 |
| 146 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01077785 |
| 147 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01077785 |
| 148 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00534839 |
| 149 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00224100 |
| 150 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99800482 |
| 151 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99652634 |
| 152 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99644859 |
| 153 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99121585 |
| 154 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98958806 |
| 155 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98573201 |
| 156 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.97221179 |
| 157 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97079159 |
| 158 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96679630 |
| 159 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.96084681 |
| 160 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95741866 |
| 161 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95559080 |
| 162 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95016626 |
| 163 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.94970922 |
| 164 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94806864 |
| 165 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94761452 |
| 166 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.94492952 |
| 167 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94227216 |
| 168 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93779985 |
| 169 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90082793 |
| 170 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89314630 |
| 171 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87925123 |
| 172 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.87135129 |
| 173 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.85254175 |
| 174 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84931111 |
| 175 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84282363 |
| 176 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81974117 |
| 177 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81765992 |
| 178 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.80318537 |
| 179 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79774003 |
| 180 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79261473 |
| 181 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.78320693 |
| 182 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77682647 |
| 183 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.77514203 |
| 184 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.77424155 |
| 185 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77126748 |
| 186 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77082763 |
| 187 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.76976468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 5.50652039 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 5.09427253 |
| 3 | MP0001873_stomach_inflammation | 4.61947841 |
| 4 | MP0002132_abnormal_respiratory_system | 3.98152705 |
| 5 | MP0003300_gastrointestinal_ulcer | 3.80218053 |
| 6 | MP0003690_abnormal_glial_cell | 3.39354015 |
| 7 | MP0001348_abnormal_lacrimal_gland | 3.30590659 |
| 8 | MP0006054_spinal_hemorrhage | 3.26928993 |
| 9 | MP0001346_abnormal_lacrimal_gland | 2.81235508 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 2.73420448 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.65100164 |
| 12 | MP0003787_abnormal_imprinting | 2.59370828 |
| 13 | MP0004883_abnormal_blood_vessel | 2.37495410 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.32821190 |
| 15 | MP0002405_respiratory_system_inflammati | 2.27617508 |
| 16 | MP0003880_abnormal_central_pattern | 2.23710289 |
| 17 | MP0005171_absent_coat_pigmentation | 2.22312834 |
| 18 | MP0001958_emphysema | 2.13664561 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.13431569 |
| 20 | MP0005645_abnormal_hypothalamus_physiol | 2.11242642 |
| 21 | MP0009785_altered_susceptibility_to | 2.08563588 |
| 22 | MP0000604_amyloidosis | 2.05881938 |
| 23 | MP0003279_aneurysm | 2.05397178 |
| 24 | MP0006082_CNS_inflammation | 1.99240807 |
| 25 | MP0000681_abnormal_thyroid_gland | 1.95787661 |
| 26 | MP0005671_abnormal_response_to | 1.95154863 |
| 27 | MP0004742_abnormal_vestibular_system | 1.91128991 |
| 28 | MP0005164_abnormal_response_to | 1.87320557 |
| 29 | MP0001851_eye_inflammation | 1.79098293 |
| 30 | MP0009745_abnormal_behavioral_response | 1.76389858 |
| 31 | MP0002998_abnormal_bone_remodeling | 1.76011098 |
| 32 | MP0005310_abnormal_salivary_gland | 1.75240940 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.74771567 |
| 34 | MP0002064_seizures | 1.72493282 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.69170779 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.67748598 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.65637050 |
| 38 | MP0002735_abnormal_chemical_nociception | 1.62463132 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.60466340 |
| 40 | MP0002277_abnormal_respiratory_mucosa | 1.57270747 |
| 41 | MP0001664_abnormal_digestion | 1.53465518 |
| 42 | MP0009764_decreased_sensitivity_to | 1.53161648 |
| 43 | MP0002160_abnormal_reproductive_system | 1.49132108 |
| 44 | MP0002419_abnormal_innate_immunity | 1.45683461 |
| 45 | MP0004885_abnormal_endolymph | 1.42457820 |
| 46 | MP0005166_decreased_susceptibility_to | 1.42197392 |
| 47 | MP0003879_abnormal_hair_cell | 1.41790133 |
| 48 | MP0009278_abnormal_bone_marrow | 1.40431979 |
| 49 | MP0001663_abnormal_digestive_system | 1.39983920 |
| 50 | MP0005387_immune_system_phenotype | 1.36110255 |
| 51 | MP0001790_abnormal_immune_system | 1.36110255 |
| 52 | MP0002063_abnormal_learning/memory/cond | 1.33622547 |
| 53 | MP0003045_fibrosis | 1.33577537 |
| 54 | MP0005646_abnormal_pituitary_gland | 1.28792133 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.28690107 |
| 56 | MP0000716_abnormal_immune_system | 1.28124973 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.25887887 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.25179727 |
| 59 | MP0000685_abnormal_immune_system | 1.24236831 |
| 60 | MP0003303_peritoneal_inflammation | 1.23974480 |
| 61 | MP0003448_altered_tumor_morphology | 1.23432030 |
| 62 | MP0001968_abnormal_touch/_nociception | 1.23321520 |
| 63 | MP0000767_abnormal_smooth_muscle | 1.18036665 |
| 64 | MP0000013_abnormal_adipose_tissue | 1.17475725 |
| 65 | MP0003436_decreased_susceptibility_to | 1.17436103 |
| 66 | MP0001905_abnormal_dopamine_level | 1.17043487 |
| 67 | MP0009046_muscle_twitch | 1.15951352 |
| 68 | MP0002398_abnormal_bone_marrow | 1.15443715 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.15120926 |
| 70 | MP0003866_abnormal_defecation | 1.15099329 |
| 71 | MP0000858_altered_metastatic_potential | 1.14719019 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 1.13078741 |
| 73 | MP0000920_abnormal_myelination | 1.12747354 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.12029385 |
| 75 | MP0002272_abnormal_nervous_system | 1.11222017 |
| 76 | MP0001486_abnormal_startle_reflex | 1.11109182 |
| 77 | MP0003183_abnormal_peptide_metabolism | 1.10180369 |
| 78 | MP0001485_abnormal_pinna_reflex | 1.10098207 |
| 79 | MP0001765_abnormal_ion_homeostasis | 1.09832330 |
| 80 | MP0002067_abnormal_sensory_capabilities | 1.09397727 |
| 81 | MP0005389_reproductive_system_phenotype | 1.07626414 |
| 82 | MP0005647_abnormal_sex_gland | 1.06876728 |
| 83 | MP0005451_abnormal_body_composition | 1.06327407 |
| 84 | MP0002148_abnormal_hypersensitivity_rea | 1.05151370 |
| 85 | MP0002736_abnormal_nociception_after | 1.04468416 |
| 86 | MP0004484_altered_response_of | 1.04156705 |
| 87 | MP0000538_abnormal_urinary_bladder | 1.04080549 |
| 88 | MP0001440_abnormal_grooming_behavior | 1.00523419 |
| 89 | MP0010386_abnormal_urinary_bladder | 1.00102256 |
| 90 | MP0004036_abnormal_muscle_relaxation | 1.00101009 |
| 91 | MP0002722_abnormal_immune_system | 0.99595058 |
| 92 | MP0001963_abnormal_hearing_physiology | 0.99299192 |
| 93 | MP0000689_abnormal_spleen_morphology | 0.98858299 |
| 94 | MP0008569_lethality_at_weaning | 0.98777293 |
| 95 | MP0001915_intracranial_hemorrhage | 0.97655772 |
| 96 | MP0003329_amyloid_beta_deposits | 0.97257238 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.97195684 |
| 98 | MP0001502_abnormal_circadian_rhythm | 0.96878468 |
| 99 | MP0001800_abnormal_humoral_immune | 0.96372181 |
| 100 | MP0002452_abnormal_antigen_presenting | 0.95903805 |
| 101 | MP0008469_abnormal_protein_level | 0.95172506 |
| 102 | MP0001970_abnormal_pain_threshold | 0.95084064 |
| 103 | MP0005381_digestive/alimentary_phenotyp | 0.94973719 |
| 104 | MP0002429_abnormal_blood_cell | 0.92836226 |
| 105 | MP0008874_decreased_physiological_sensi | 0.92788654 |
| 106 | MP0003724_increased_susceptibility_to | 0.92456977 |
| 107 | MP0000249_abnormal_blood_vessel | 0.91697768 |
| 108 | MP0005503_abnormal_tendon_morphology | 0.90866052 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.88691088 |
| 110 | MP0009763_increased_sensitivity_to | 0.88307104 |
| 111 | MP0003136_yellow_coat_color | 0.87971871 |
| 112 | MP0003633_abnormal_nervous_system | 0.87792915 |
| 113 | MP0001881_abnormal_mammary_gland | 0.86175803 |
| 114 | MP0001835_abnormal_antigen_presentation | 0.85654217 |
| 115 | MP0005025_abnormal_response_to | 0.85449583 |
| 116 | MP0000462_abnormal_digestive_system | 0.83916180 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.83188570 |
| 118 | MP0002420_abnormal_adaptive_immunity | 0.82307800 |
| 119 | MP0001819_abnormal_immune_cell | 0.81810661 |
| 120 | MP0002723_abnormal_immune_serum | 0.80980506 |
| 121 | MP0003950_abnormal_plasma_membrane | 0.80854679 |
| 122 | MP0002837_dystrophic_cardiac_calcinosis | 0.80307416 |
| 123 | MP0002557_abnormal_social/conspecific_i | 0.79590911 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.78762336 |
| 125 | MP0000026_abnormal_inner_ear | 0.78385344 |
| 126 | MP0000613_abnormal_salivary_gland | 0.75920688 |
| 127 | MP0002733_abnormal_thermal_nociception | 0.75743235 |
| 128 | MP0005023_abnormal_wound_healing | 0.75244650 |
| 129 | MP0006292_abnormal_olfactory_placode | 0.72703345 |
| 130 | MP0003122_maternal_imprinting | 0.72545583 |
| 131 | MP0005275_abnormal_skin_tensile | 0.72149179 |
| 132 | MP0005000_abnormal_immune_tolerance | 0.71384204 |
| 133 | MP0001919_abnormal_reproductive_system | 0.71288796 |
| 134 | MP0001529_abnormal_vocalization | 0.70875160 |
| 135 | MP0003191_abnormal_cellular_cholesterol | 0.69717509 |
| 136 | MP0003631_nervous_system_phenotype | 0.69486091 |
| 137 | MP0000470_abnormal_stomach_morphology | 0.68245371 |
| 138 | MP0002166_altered_tumor_susceptibility | 0.67889947 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.66970533 |
| 140 | MP0005448_abnormal_energy_balance | 0.60487956 |
| 141 | MP0003075_altered_response_to | 0.60032061 |
| 142 | MP0005197_abnormal_uvea_morphology | 0.57701284 |
| 143 | MP0004947_skin_inflammation | 0.57488135 |
| 144 | MP0002396_abnormal_hematopoietic_system | 0.50289794 |
| 145 | MP0005376_homeostasis/metabolism_phenot | 0.46910108 |
| 146 | MP0004381_abnormal_hair_follicle | 0.46030517 |
| 147 | MP0002933_joint_inflammation | 0.45751905 |
| 148 | MP0001986_abnormal_taste_sensitivity | 0.45461243 |
| 149 | MP0001984_abnormal_olfaction | 0.44381080 |
| 150 | MP0009840_abnormal_foam_cell | 0.43693070 |
| 151 | MP0008873_increased_physiological_sensi | 0.42170341 |
| 152 | MP0001119_abnormal_female_reproductive | 0.41287641 |
| 153 | MP0001545_abnormal_hematopoietic_system | 0.38828313 |
| 154 | MP0005397_hematopoietic_system_phenotyp | 0.38828313 |
| 155 | MP0000477_abnormal_intestine_morphology | 0.38590338 |
| 156 | MP0002006_tumorigenesis | 0.37750230 |
| 157 | MP0003011_delayed_dark_adaptation | 0.37541031 |
| 158 | MP0000490_abnormal_crypts_of | 0.35003621 |
| 159 | MP0008004_abnormal_stomach_pH | 0.34553816 |
| 160 | MP0005390_skeleton_phenotype | 0.33887109 |
| 161 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.33380013 |
| 162 | MP0003693_abnormal_embryo_hatching | 0.31656299 |
| 163 | MP0003828_pulmonary_edema | 0.31637429 |
| 164 | MP0002163_abnormal_gland_morphology | 0.30372275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Brushfield spots (HP:0001088) | 7.36624795 |
| 2 | Flat occiput (HP:0005469) | 6.30160111 |
| 3 | Chronic mucocutaneous candidiasis (HP:0002728) | 6.13695298 |
| 4 | Recurrent cutaneous fungal infections (HP:0011370) | 6.13695298 |
| 5 | Stomatitis (HP:0010280) | 6.07766371 |
| 6 | Nasal polyposis (HP:0100582) | 6.01632853 |
| 7 | Spondylolisthesis (HP:0003302) | 5.38705063 |
| 8 | Recurrent fungal infections (HP:0002841) | 5.23066862 |
| 9 | Keratoconjunctivitis (HP:0001096) | 5.20670861 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 5.16453109 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 5.03511010 |
| 12 | Absent frontal sinuses (HP:0002688) | 4.91316085 |
| 13 | Increased IgM level (HP:0003496) | 4.69928415 |
| 14 | Aortic dissection (HP:0002647) | 4.56491897 |
| 15 | Focal motor seizures (HP:0011153) | 4.54814955 |
| 16 | Pustule (HP:0200039) | 4.52381048 |
| 17 | Hyperventilation (HP:0002883) | 4.49154888 |
| 18 | Arterial tortuosity (HP:0005116) | 4.39251117 |
| 19 | Abnormality of T cell number (HP:0011839) | 4.29260511 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.24787644 |
| 21 | Ulnar bowing (HP:0003031) | 4.23629817 |
| 22 | Chronic sinusitis (HP:0011109) | 4.18664782 |
| 23 | Purpura (HP:0000979) | 4.17817952 |
| 24 | Abnormality of macrophages (HP:0004311) | 4.03785554 |
| 25 | Agammaglobulinemia (HP:0004432) | 4.03178859 |
| 26 | Premature rupture of membranes (HP:0001788) | 3.97644262 |
| 27 | Asplenia (HP:0001746) | 3.90774299 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.84249574 |
| 29 | Vascular tortuosity (HP:0004948) | 3.83035087 |
| 30 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.77426679 |
| 31 | Decreased circulating renin level (HP:0003351) | 3.77338445 |
| 32 | Primary adrenal insufficiency (HP:0008207) | 3.75592047 |
| 33 | Autoimmune hemolytic anemia (HP:0001890) | 3.75052208 |
| 34 | Cellulitis (HP:0100658) | 3.74172384 |
| 35 | Recurrent skin infections (HP:0001581) | 3.73234417 |
| 36 | Increased IgE level (HP:0003212) | 3.68735167 |
| 37 | Epiphyseal stippling (HP:0010655) | 3.66614062 |
| 38 | Eczematoid dermatitis (HP:0000976) | 3.58653780 |
| 39 | Delayed closure of the anterior fontanelle (HP:0001476) | 3.53486150 |
| 40 | Hypoproteinemia (HP:0003075) | 3.53201008 |
| 41 | Abnormality of T cells (HP:0002843) | 3.52684111 |
| 42 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 3.51849160 |
| 43 | Aortic aneurysm (HP:0004942) | 3.49171105 |
| 44 | Stomach cancer (HP:0012126) | 3.45945400 |
| 45 | Osteomyelitis (HP:0002754) | 3.35656473 |
| 46 | Thyroiditis (HP:0100646) | 3.34451816 |
| 47 | Epileptic encephalopathy (HP:0200134) | 3.31504079 |
| 48 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.23797321 |
| 49 | T lymphocytopenia (HP:0005403) | 3.22752769 |
| 50 | Hypochromic anemia (HP:0001931) | 3.21606058 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.20833234 |
| 52 | Abnormality of the frontal sinuses (HP:0002687) | 3.17700780 |
| 53 | Myositis (HP:0100614) | 3.14580757 |
| 54 | Petechiae (HP:0000967) | 3.12854300 |
| 55 | Recurrent bacterial skin infections (HP:0005406) | 3.11525724 |
| 56 | Recurrent abscess formation (HP:0002722) | 3.08775854 |
| 57 | Spontaneous abortion (HP:0005268) | 3.07896424 |
| 58 | Posterior embryotoxon (HP:0000627) | 3.07702183 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 3.05992585 |
| 60 | Recurrent bronchitis (HP:0002837) | 3.00865019 |
| 61 | Abnormality of the line of Schwalbe (HP:0008048) | 3.00526187 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.97455508 |
| 63 | Thickened nuchal skin fold (HP:0000474) | 2.97282785 |
| 64 | Cerebral aneurysm (HP:0004944) | 2.95426942 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 2.95287178 |
| 66 | Febrile seizures (HP:0002373) | 2.94657399 |
| 67 | Verrucae (HP:0200043) | 2.93297191 |
| 68 | Papilloma (HP:0012740) | 2.93297191 |
| 69 | Female pseudohermaphroditism (HP:0010458) | 2.93266751 |
| 70 | Delayed cranial suture closure (HP:0000270) | 2.91653235 |
| 71 | B lymphocytopenia (HP:0010976) | 2.90716161 |
| 72 | Abnormality of B cell number (HP:0010975) | 2.90716161 |
| 73 | Vasculitis (HP:0002633) | 2.88426145 |
| 74 | Mitral stenosis (HP:0001718) | 2.87627508 |
| 75 | Encephalitis (HP:0002383) | 2.86375151 |
| 76 | Keratitis (HP:0000491) | 2.86094436 |
| 77 | Lymphopenia (HP:0001888) | 2.86084100 |
| 78 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.82815693 |
| 79 | Hypercortisolism (HP:0001578) | 2.80658893 |
| 80 | Persistence of primary teeth (HP:0006335) | 2.79545428 |
| 81 | Chronic diarrhea (HP:0002028) | 2.79193700 |
| 82 | Oral leukoplakia (HP:0002745) | 2.78500849 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78278463 |
| 84 | Obstructive lung disease (HP:0006536) | 2.78278463 |
| 85 | Anorexia (HP:0002039) | 2.77812308 |
| 86 | Atonic seizures (HP:0010819) | 2.76788117 |
| 87 | Neoplasm of the heart (HP:0100544) | 2.76027642 |
| 88 | Vertebral arch anomaly (HP:0008438) | 2.75944182 |
| 89 | Orchitis (HP:0100796) | 2.72534852 |
| 90 | Hemiplegia (HP:0002301) | 2.69967877 |
| 91 | Abnormality of eosinophils (HP:0001879) | 2.69948235 |
| 92 | Leukocytosis (HP:0001974) | 2.68740103 |
| 93 | Optic neuritis (HP:0100653) | 2.64824664 |
| 94 | Retrobulbar optic neuritis (HP:0100654) | 2.64824664 |
| 95 | Type I diabetes mellitus (HP:0100651) | 2.64594379 |
| 96 | Bowed forearm bones (HP:0003956) | 2.63061749 |
| 97 | Bowing of the arm (HP:0006488) | 2.63061749 |
| 98 | Syringomyelia (HP:0003396) | 2.62565257 |
| 99 | Spinal cord lesions (HP:0100561) | 2.62565257 |
| 100 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.59612854 |
| 101 | Pulmonary artery stenosis (HP:0004415) | 2.57753076 |
| 102 | Granulocytopenia (HP:0001913) | 2.54644924 |
| 103 | Congenital sensorineural hearing impairment (HP:0008527) | 2.54368402 |
| 104 | Radial bowing (HP:0002986) | 2.53938477 |
| 105 | Recurrent pneumonia (HP:0006532) | 2.52024865 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51495303 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51495303 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51495303 |
| 109 | Hypoplasia of the thymus (HP:0000778) | 2.50397089 |
| 110 | Gingival bleeding (HP:0000225) | 2.48540284 |
| 111 | Abnormal epiphyseal ossification (HP:0010656) | 2.48019925 |
| 112 | Narrow nasal bridge (HP:0000446) | 2.47960711 |
| 113 | Pyloric stenosis (HP:0002021) | 2.47120341 |
| 114 | Meningitis (HP:0001287) | 2.46601855 |
| 115 | Broad-based gait (HP:0002136) | 2.46588116 |
| 116 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.40446277 |
| 117 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.39648508 |
| 118 | Mucopolysacchariduria (HP:0008155) | 2.39648508 |
| 119 | Dysostosis multiplex (HP:0000943) | 2.38482434 |
| 120 | Sepsis (HP:0100806) | 2.37419425 |
| 121 | Abnormal hair whorl (HP:0010721) | 2.34673404 |
| 122 | Aplastic anemia (HP:0001915) | 2.32371302 |
| 123 | Hyperthyroidism (HP:0000836) | 2.30748262 |
| 124 | Papilledema (HP:0001085) | 2.30087888 |
| 125 | Hypoparathyroidism (HP:0000829) | 2.29759071 |
| 126 | Alopecia of scalp (HP:0002293) | 2.28379442 |
| 127 | Cheilitis (HP:0100825) | 2.28214622 |
| 128 | Protruding tongue (HP:0010808) | 2.26411326 |
| 129 | Mediastinal lymphadenopathy (HP:0100721) | 2.24464069 |
| 130 | Deep philtrum (HP:0002002) | 2.23479577 |
| 131 | Urticaria (HP:0001025) | 2.21970983 |
| 132 | Recurrent viral infections (HP:0004429) | 2.19954441 |
| 133 | Loss of speech (HP:0002371) | 2.19584336 |
| 134 | Diplopia (HP:0000651) | 2.17753944 |
| 135 | Abnormality of binocular vision (HP:0011514) | 2.17753944 |
| 136 | Underdeveloped supraorbital ridges (HP:0009891) | 2.15249634 |
| 137 | Tetany (HP:0001281) | 2.14887586 |
| 138 | Joint swelling (HP:0001386) | 2.14617927 |
| 139 | Gastrointestinal stroma tumor (HP:0100723) | 2.13972156 |
| 140 | Abnormal delivery (HP:0001787) | 2.13339015 |
| 141 | Exotropia (HP:0000577) | 2.12655521 |
| 142 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.12051788 |
| 143 | Osteolytic defects of the hand bones (HP:0009699) | 2.12051788 |
| 144 | Conjugated hyperbilirubinemia (HP:0002908) | 2.10738817 |
| 145 | Homocystinuria (HP:0002156) | 2.09514554 |
| 146 | Abnormality of homocysteine metabolism (HP:0010919) | 2.09514554 |
| 147 | Widely spaced teeth (HP:0000687) | 2.08131024 |
| 148 | Panhypogammaglobulinemia (HP:0003139) | 2.07499466 |
| 149 | Oligomenorrhea (HP:0000876) | 2.05687218 |
| 150 | Aortic regurgitation (HP:0001659) | 2.04480591 |
| 151 | Pulmonary infiltrates (HP:0002113) | 2.02419880 |
| 152 | Increased density of long bones (HP:0006392) | 2.02379801 |
| 153 | Pulmonary fibrosis (HP:0002206) | 2.00563904 |
| 154 | Striae distensae (HP:0001065) | 1.99894038 |
| 155 | Oligodactyly (hands) (HP:0001180) | 1.99387841 |
| 156 | Severe combined immunodeficiency (HP:0004430) | 1.97692458 |
| 157 | Chest pain (HP:0100749) | 1.97459516 |
| 158 | Soft skin (HP:0000977) | 1.96777053 |
| 159 | Recurrent lower respiratory tract infections (HP:0002783) | 1.96668699 |
| 160 | Aqueductal stenosis (HP:0002410) | 1.96467632 |
| 161 | Keratoconjunctivitis sicca (HP:0001097) | 1.94017747 |
| 162 | Abnormality of the intervertebral disk (HP:0005108) | 1.93759007 |
| 163 | Episodic fever (HP:0001954) | 1.92948246 |
| 164 | Hypoplasia of the iris (HP:0007676) | 1.91606330 |
| 165 | Prolonged bleeding time (HP:0003010) | 1.91440798 |
| 166 | Focal seizures (HP:0007359) | 1.91127764 |
| 167 | Lymphoma (HP:0002665) | 1.91052148 |
| 168 | Spontaneous hematomas (HP:0007420) | 1.89301089 |
| 169 | Eosinophilia (HP:0001880) | 1.86157295 |
| 170 | Hepatitis (HP:0012115) | 1.84931777 |
| 171 | Hemoptysis (HP:0002105) | 1.83817992 |
| 172 | Short hallux (HP:0010109) | 1.79870217 |
| 173 | Thyroid-stimulating hormone excess (HP:0002925) | 1.77291829 |
| 174 | Blue irides (HP:0000635) | 1.77241554 |
| 175 | Dialeptic seizures (HP:0011146) | 1.77137690 |
| 176 | Abnormality of primary teeth (HP:0006481) | 1.76422483 |
| 177 | Absence seizures (HP:0002121) | 1.72841921 |
| 178 | Abnormality of glycolipid metabolism (HP:0010969) | 1.72361259 |
| 179 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.72361259 |
| 180 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.72361259 |
| 181 | Palpebral edema (HP:0100540) | 1.70136338 |
| 182 | Asymmetry of the thorax (HP:0001555) | 1.69614115 |
| 183 | Small epiphyses (HP:0010585) | 1.69369947 |
| 184 | Metabolic alkalosis (HP:0200114) | 1.68891887 |
| 185 | Sensory axonal neuropathy (HP:0003390) | 1.67239440 |
| 186 | Asymmetric septal hypertrophy (HP:0001670) | 1.64540797 |
| 187 | Abnormality of molar morphology (HP:0011070) | 1.64368938 |
| 188 | Abnormality of molar (HP:0011077) | 1.64368938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PASK | 7.93398081 |
| 2 | CASK | 7.74694961 |
| 3 | MAP3K13 | 7.61535157 |
| 4 | MAP3K10 | 4.70729993 |
| 5 | TGFBR2 | 3.51009021 |
| 6 | CAMKK1 | 3.47378287 |
| 7 | NTRK3 | 3.45680706 |
| 8 | CSK | 2.81263165 |
| 9 | MYLK | 2.80774038 |
| 10 | AKT3 | 2.53770327 |
| 11 | TNIK | 2.51114625 |
| 12 | SIK3 | 2.37509050 |
| 13 | MAP4K1 | 2.30009783 |
| 14 | TYK2 | 2.24765287 |
| 15 | SIK2 | 1.99420256 |
| 16 | MAPK12 | 1.78360166 |
| 17 | CLK1 | 1.73026328 |
| 18 | MAPK13 | 1.72609908 |
| 19 | PRPF4B | 1.70886436 |
| 20 | BTK | 1.65029068 |
| 21 | SGK2 | 1.59657044 |
| 22 | STK10 | 1.58512848 |
| 23 | INSRR | 1.47988174 |
| 24 | MAP3K11 | 1.45572503 |
| 25 | SGK3 | 1.40475298 |
| 26 | EPHB1 | 1.36680752 |
| 27 | IKBKB | 1.32814193 |
| 28 | ADRBK2 | 1.32802042 |
| 29 | ERN1 | 1.31711094 |
| 30 | SGK223 | 1.27385560 |
| 31 | SGK494 | 1.27385560 |
| 32 | MAPK7 | 1.23195223 |
| 33 | MAP2K7 | 1.23114041 |
| 34 | PLK2 | 1.21523230 |
| 35 | KDR | 1.19401701 |
| 36 | MAP3K14 | 1.15163158 |
| 37 | MAP3K12 | 1.14840766 |
| 38 | MAP3K4 | 1.14281765 |
| 39 | CCNB1 | 1.12824219 |
| 40 | TESK2 | 1.10058943 |
| 41 | FGFR2 | 1.09736902 |
| 42 | TTN | 1.04689771 |
| 43 | NTRK2 | 1.02210590 |
| 44 | MUSK | 1.00616520 |
| 45 | PIK3CG | 1.00353570 |
| 46 | IRAK4 | 1.00065127 |
| 47 | MARK3 | 0.99202316 |
| 48 | FES | 0.98156468 |
| 49 | MAP3K7 | 0.95897930 |
| 50 | TEC | 0.95867690 |
| 51 | TAOK3 | 0.93005534 |
| 52 | PRKCQ | 0.92976758 |
| 53 | SYK | 0.92371151 |
| 54 | BLK | 0.92221199 |
| 55 | RIPK4 | 0.91051300 |
| 56 | EPHA4 | 0.89706517 |
| 57 | PRKCG | 0.89236064 |
| 58 | IKBKE | 0.88947506 |
| 59 | FGFR1 | 0.88833322 |
| 60 | GRK6 | 0.87621796 |
| 61 | JAK2 | 0.86340275 |
| 62 | PRKCH | 0.81048737 |
| 63 | JAK1 | 0.80168141 |
| 64 | FGFR3 | 0.79087940 |
| 65 | DAPK1 | 0.79047812 |
| 66 | JAK3 | 0.78681798 |
| 67 | EEF2K | 0.78294570 |
| 68 | MAP2K3 | 0.76334442 |
| 69 | CDK4 | 0.75978356 |
| 70 | MAPK4 | 0.75557655 |
| 71 | GSK3A | 0.74556718 |
| 72 | CDC42BPA | 0.73892385 |
| 73 | GRK7 | 0.73029504 |
| 74 | MARK2 | 0.72204181 |
| 75 | PDGFRA | 0.71745079 |
| 76 | TBK1 | 0.71290884 |
| 77 | CDK3 | 0.70223834 |
| 78 | MKNK2 | 0.70206241 |
| 79 | NLK | 0.69768425 |
| 80 | CDK19 | 0.67213233 |
| 81 | BMPR2 | 0.66350342 |
| 82 | PRKCE | 0.66006424 |
| 83 | MAPK11 | 0.61464715 |
| 84 | MAP3K3 | 0.60177421 |
| 85 | LRRK2 | 0.59209216 |
| 86 | CSF1R | 0.59195626 |
| 87 | TRPM7 | 0.58225978 |
| 88 | HCK | 0.51514512 |
| 89 | ITK | 0.50392139 |
| 90 | DMPK | 0.50319075 |
| 91 | TAOK1 | 0.50300344 |
| 92 | CAMK1 | 0.50214327 |
| 93 | LYN | 0.49586350 |
| 94 | SGK1 | 0.49114418 |
| 95 | MAP3K1 | 0.48243222 |
| 96 | CHUK | 0.47849549 |
| 97 | PIM1 | 0.47549890 |
| 98 | TSSK6 | 0.45940637 |
| 99 | ROCK2 | 0.45659641 |
| 100 | SRC | 0.45010962 |
| 101 | PDPK1 | 0.44452145 |
| 102 | OXSR1 | 0.43389096 |
| 103 | KIT | 0.42515688 |
| 104 | ZAP70 | 0.42176162 |
| 105 | PKN1 | 0.41442564 |
| 106 | CDK5 | 0.41353851 |
| 107 | DYRK1B | 0.41152046 |
| 108 | PDK1 | 0.41133160 |
| 109 | STK4 | 0.39396135 |
| 110 | NEK9 | 0.39355713 |
| 111 | DAPK2 | 0.38964100 |
| 112 | YES1 | 0.38661615 |
| 113 | ERBB3 | 0.35598420 |
| 114 | FYN | 0.35484162 |
| 115 | HIPK2 | 0.35403508 |
| 116 | ABL1 | 0.35329817 |
| 117 | MAP2K4 | 0.34906568 |
| 118 | TNK2 | 0.34633061 |
| 119 | FGR | 0.34142967 |
| 120 | CAMK2B | 0.33366049 |
| 121 | CAMK2A | 0.32888647 |
| 122 | TXK | 0.32506035 |
| 123 | EPHA3 | 0.31481294 |
| 124 | MAPKAPK5 | 0.31075917 |
| 125 | LCK | 0.30777622 |
| 126 | PRKAA2 | 0.29826591 |
| 127 | FRK | 0.29254047 |
| 128 | NME1 | 0.28148844 |
| 129 | PRKD2 | 0.27999609 |
| 130 | MAPK3 | 0.27534831 |
| 131 | PRKG2 | 0.27469625 |
| 132 | BCR | 0.26112729 |
| 133 | PRKCB | 0.25509941 |
| 134 | EIF2AK3 | 0.25274241 |
| 135 | PTK2B | 0.24434374 |
| 136 | PRKG1 | 0.24191075 |
| 137 | ERBB4 | 0.23218732 |
| 138 | SIK1 | 0.23127221 |
| 139 | MST4 | 0.22651334 |
| 140 | NEK6 | 0.22609129 |
| 141 | MAP3K5 | 0.22359529 |
| 142 | CAMKK2 | 0.19756881 |
| 143 | MAP2K6 | 0.19708501 |
| 144 | ALK | 0.19699529 |
| 145 | MATK | 0.19321608 |
| 146 | TAOK2 | 0.18302134 |
| 147 | INSR | 0.13211991 |
| 148 | PRKCZ | 0.13199772 |
| 149 | MAPK1 | 0.12880174 |
| 150 | RPS6KA4 | 0.12530639 |
| 151 | IGF1R | 0.09748540 |
| 152 | TLK1 | 0.09596015 |
| 153 | STK38 | 0.08828206 |
| 154 | PRKCA | 0.07292907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.97913615 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.76296989 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.54325745 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.50131718 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.38961901 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.37379166 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.26059394 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.23953907 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.22894660 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.22177803 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.17768947 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.09289921 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.06833660 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.81616899 |
| 15 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.79611260 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.74108449 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 1.73725047 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.65118178 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.57638161 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50725179 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.50342090 |
| 22 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.49884680 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46176420 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.46077194 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45069769 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44994096 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44879168 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.43855817 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.42366594 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.42053142 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.40631393 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39968486 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35134738 |
| 34 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.34244927 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.31684312 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23632411 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.23614847 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22533886 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22278578 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.21123873 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19061885 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17393890 |
| 43 | Taste transduction_Homo sapiens_hsa04742 | 1.16066537 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.14207059 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.12254359 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11710351 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.11199319 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11159401 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.11073015 |
| 50 | Leishmaniasis_Homo sapiens_hsa05140 | 1.09814038 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07662788 |
| 52 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.06389296 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.04309588 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 1.02900791 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 1.01470428 |
| 56 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.00146798 |
| 57 | Asthma_Homo sapiens_hsa05310 | 0.98127242 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97102005 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96197784 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94472219 |
| 61 | Long-term potentiation_Homo sapiens_hsa04720 | 0.94426382 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.93349543 |
| 63 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90935801 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88309330 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.86935810 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86794524 |
| 67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86708017 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86122087 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86108980 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.84154013 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84098716 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.79947525 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79832236 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79797182 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79777898 |
| 76 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.78541254 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.77626560 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.75775591 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.75596945 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75318965 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.74754820 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74227510 |
| 83 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73960159 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73303466 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73294771 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72307382 |
| 87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71886204 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70066550 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70049877 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.67767261 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66651028 |
| 92 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66463703 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65388063 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.65238043 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65176578 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64310614 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.64030934 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63648233 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62430783 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62416236 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61497397 |
| 102 | Focal adhesion_Homo sapiens_hsa04510 | 0.60147858 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59664672 |
| 104 | Long-term depression_Homo sapiens_hsa04730 | 0.59269313 |
| 105 | Malaria_Homo sapiens_hsa05144 | 0.58950487 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.57506953 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56647555 |
| 108 | Axon guidance_Homo sapiens_hsa04360 | 0.56448207 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.56098684 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55726110 |
| 111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55671899 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55526838 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.54776032 |
| 114 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53506017 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53367882 |
| 116 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52478121 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52256292 |
| 118 | RNA degradation_Homo sapiens_hsa03018 | 0.51605587 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.51301570 |
| 120 | Measles_Homo sapiens_hsa05162 | 0.51201084 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51049849 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50622924 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49957446 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49096657 |
| 125 | Melanoma_Homo sapiens_hsa05218 | 0.49023955 |
| 126 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48660396 |
| 127 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48314704 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48007033 |
| 129 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47953105 |
| 130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47007741 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.44866192 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44504647 |
| 133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44027736 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41795529 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34967596 |
| 136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31245871 |
| 137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26075857 |
| 138 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24998372 |
| 139 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.23750222 |
| 140 | Circadian rhythm_Homo sapiens_hsa04710 | 0.22828390 |
| 141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21024204 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20609824 |
| 143 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18540895 |
| 144 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.18066385 |
| 145 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.17631152 |
| 146 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16865727 |
| 147 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.16805277 |
| 148 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14100636 |

